AEENA DX
AEENA Dx is developing a saliva-based platform for the detection of cancer and disease.
AEENA DX
Industry:
Biotechnology Genetics Health Care
Founded:
2011-01-01
Address:
Mountain View, California, United States
Country:
United States
Website Url:
http://www.aeenadx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.06 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Content Delivery Network Amazon SSL By Default Mobile Non Scaleable Content ReCAPTCHA Google Apps For Business GStatic Google Static Content Apple Mobile Web App Capable
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Current Employees Featured
Founder
Investors List
Portfolia
Portfolia investment in Series A - AEENA Dx
Portfolia
Portfolia investment in Series A - AEENA Dx
Jennifer Ehlen
Jennifer Ehlen investment in Series A - AEENA Dx
Portfolia
Portfolia investment in Series A - AEENA Dx
Portfolia
Portfolia investment in Series A - AEENA Dx
Jennifer Ehlen
Jennifer Ehlen investment in Series A - AEENA Dx
Portfolia
Portfolia investment in Series A - AEENA Dx
Nola Masterson
Nola Masterson investment in Series A - AEENA Dx
DigitalDx Ventures
DigitalDx Ventures investment in Series A - AEENA Dx
Iron Yard Ventures
Iron Yard Ventures investment in Seed Round - AEENA Dx
Key Employee Changes
Date | New article |
---|---|
2020-10-29 | Prime Genomics Welcomes Robert Weigle as CEO |
Official Site Inspections
http://www.aeenadx.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AEENA Dx"
AEENA Dx - Crunchbase Company Profile & Funding
Organization. AEENA Dx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; AEENA Dx โฆSee details»
AEENA Dx Company Profile 2024: Valuation, Investors โฆ
Information on acquisition, funding, cap tables, investors, and executives for AEENA Dx. Use the PitchBook Platform to explore the full profile.See details»
AeenaDx Overview | SignalHire Company Profile
AeenaDx is a private company that has been in the industry for 13 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by Robert Weigle โฆSee details»
AEENA Dx, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore AEENA Dx, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Silicon Valley-based Diagnostics Company AEENA Dx Welcomes โฆ
May 24, 2022 There were 793 press releases posted in the last 24 hours and 396,684 in the last 365 days.See details»
Michele Colucci, Esq.โs Post - LinkedIn
AeenaDx Board Chair Michele Colucci, who will remain on the Board, adds "The synergies of the combined C-Suite, a robust line of tests going to market, and a healthy R&D pipeline, all serve to ...See details»
Robert Weigleโs Post - LinkedIn
AeenaDx Board Chair Michele Colucci, who will remain on the Board, adds "The synergies of the combined C-Suite, a robust line of tests going to market, and a healthy R&D pipeline, all serve to ...See details»
NowDx Using $22.5M Funding Round to Bring OTC Syphilis Test โฆ
AeenaDx merged with NowDx in April 2023. Weigle said that while NowDx has retained AeenaDx's intellectual property, including an RNA collection device capable of storing samples โฆSee details»
AeenaDX - GitHub
GitHub is where AeenaDX builds software. GitHub is where AeenaDX builds software. Skip to content. Navigation Menu Toggle navigation. Sign in AeenaDX. Product GitHub Copilot. Write โฆSee details»
AEENA Dx - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
ADEXUSDx® COVID-19 Test Receives Conformité โฆ
NOWDx and AeenaDx Announce Merger Todd Simpson. We are pleased to announce the merger of NOWDx and AEENA Dx. The combined entity will directly address healthcareโs expansive need for POC and OTC diagnostics at โฆSee details»
Clete Brewer posted on LinkedIn
AeenaDx Board Chair Michele Colucci, who will remain on the Board, adds "The synergies of the combined C-Suite, a robust line of tests going to market, and a healthy R&D pipeline, all serve โฆSee details»
Silicon Valley-based Diagnostics Company AEENA Dx Welcomes โฆ
AEENA Dx welcomes new Board member Jerry Lanchbury, Ph.D. AEENA Dx is now leveraging its technology and deep knowledge to develop non-invasive tests for aSee details»
Robert Weigle / Chief Executive Officer โ NOWDx
Rob ert K. Weigle currently is and has been since April 1, 2023, the CEO of NOW Diagnostics. From October 2020 to March 2023, he was the CEO of AeenaDX, a saliva-based diagnostics โฆSee details»
Series A - AEENA Dx - 2021-12-03 - Crunchbase
Dec 3, 2021 Organization Name . AEENA Dx . Announced Date Dec 3, 2021; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. Pre โฆSee details»
List of 5 AeenaDx Employees - Find Emails & Phones - SignalHire
AeenaDx United States employs 5 employees. Reveal contacts of top AeenaDx managers and employees.See details»
Members · People · AeenaDX - GitHub
Saved searches Use saved searches to filter your results more quicklySee details»
NOWDiagnostics Secures $22.5 Million in Series B Funding
SPRINGDALE, Ark., July 09, 2024--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced it has raised $22.5 โฆSee details»
2024 Senate Accessibility Plan Progress Report
5 days ago H. Organization-wide initiatives Accessibility plan goals achieved or in progress in 2024. Goal: By the end of 2024, the Senate will implement organization-wide disability and โฆSee details»
NOWDiagnostics Secures $22.5 Million in Series B Funding
Jul 9, 2024 NOWDiagnostics, Inc., a developer of over-the-counter and point-of-care diagnostic tests, today announced it has raised $22.5 million in Series B financing. Led by DigitalDx โฆSee details»